(S)-Veliflapon is an orally active inhibitor of leukotriene biosynthesis and 5-lipoxygenase-activating protein (FLAP); it inhibits leukotriene B4 (LTB4) formation in rat, mouse, and human leukocytes with IC50 values of 0.026 µM, 0.039 µM, and 0.22 µM, respectively; it exhibits enantioselectivity in human whole blood.